Book contents
- Frontmatter
- Contents
- List of contributors
- Foreword
- Preface
- Part 1 Disorders of intellectual development: concept and epidemiology
- Part 2 Disorders of intellectual development: comorbidity and complications
- 3 Psychiatric illness and disorders of intellectual development: a dual diagnosis
- 4 Anxiety disorders
- 5 Behaviour problems
- 6 Epilepsy
- 7 The use of psychotropic medications to manage problem behaviours in adults
- Part 3 Autism spectrum disorder
- Part 4 Service provision
- Index
7 - The use of psychotropic medications to manage problem behaviours in adults
from Part 2 - Disorders of intellectual development: comorbidity and complications
Published online by Cambridge University Press: 01 January 2018
- Frontmatter
- Contents
- List of contributors
- Foreword
- Preface
- Part 1 Disorders of intellectual development: concept and epidemiology
- Part 2 Disorders of intellectual development: comorbidity and complications
- 3 Psychiatric illness and disorders of intellectual development: a dual diagnosis
- 4 Anxiety disorders
- 5 Behaviour problems
- 6 Epilepsy
- 7 The use of psychotropic medications to manage problem behaviours in adults
- Part 3 Autism spectrum disorder
- Part 4 Service provision
- Index
Summary
A high proportion of people with disorders of intellectual development (DID) receive medication for both physical and mental health conditions (Deb & Fraser, 1994). Psychotropic medications are commonly used to manage problem behaviours when no diagnosis of a psychiatric disorder can be confirmed. The accurate diagnosis of psychiatric disorders can be particularly difficult in people with DID (Deb et al, 2001; Hemmings et al, 2013). Problem behaviour in this context is defined as ‘socially unacceptable behaviour that causes distress, harm or disadvantage to the person themselves or to other people or damage to property, and usually requires some intervention’ (Deb et al, 2009: p. 182). Other terms have also been used to describe problem behaviours, such as challenging behaviour, behaviour disorder and behaviour difficulty. Examples of problem behaviours include aggression to other people (physical or verbal aggression), property destruction and self-injurious behaviour (for a more detailed description of problem behaviours see Chapter 5).
There is concern about the use of psychotropic medication in people with DID for the management of problem behaviours in the absence of a diagnosed psychiatric disorder. Some of the reasons for this are:
• perceived excessive use of medication – multiple medications are often used at a high dose for a long period of time without any review, and sometimes exceeding the British National Formulary (BNF) (http:// www.bnf.org) recommended maximum dose
• adverse events, such as weight gain and somnolence from risperidone, and the difficulty of assessing these in people with DID, including the carrying out of necessary investigations such as serum lithium level and other blood tests
• lack of evidence of effectiveness
• out-of-licence use, as, by and large, these medications are licensed for the treatment of psychiatric disorders, not of problem behaviours
• use of medication without explicit patient consent, as is often the case in relation to people with DID.
Because of this wide public concern, a national guide on the use of medication for the management of problem behaviours in people with DID was developed in the UK on behalf of the Royal College of Psychiatrists (Unwin & Deb, 2010), and subsequently an adapted version of the UK guide was published as an international guide (Deb et al, 2009) on behalf of the World Psychiatric Association (WPA).
- Type
- Chapter
- Information
- Clinical Topics in Disorders of Intellectual Development , pp. 130 - 144Publisher: Royal College of PsychiatristsPrint publication year: 2015